Recruiting Hypertension Studies in Stanford
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study...
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
Researchers are looking for new ways to treat people with a type of pulmonary hypertension called combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). This study focuses on Cpc-PH ...
About Hypertension Clinical Trials in Stanford
Hypertension, or high blood pressure, is a common condition that increases the risk of heart disease, stroke, and kidney damage. Often called the "silent killer" because it usually has no symptoms. Management includes lifestyle modifications and medications to lower blood pressure.
There are currently 2 hypertension clinical trials recruiting participants in Stanford, CALIFORNIA. These studies are seeking a combined 430 participants. Research is being sponsored by GB002, Inc., Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hypertension Clinical Trials in Stanford — FAQ
Are there hypertension clinical trials in Stanford?
Yes, there are 2 hypertension clinical trials currently recruiting in Stanford, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stanford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.
Are clinical trials in Stanford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.
What hypertension treatments are being tested?
The 2 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov